Ledger.Open graph →
SEC Form D · Amendment · filed March 10, 2023

Genecis Bioindustries Inc

Offering
$3.3M
Sold
$3.3M
Exemption
Rule 506(b)
Industry
Other
Location
SCARBOROUGH, Z4
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (2)

Shlomo Seidenfeld · Brooklyn, NYExec · DirectorCharles Yeomans · Moraga, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗